CSNK2A1 Human, His

Casein Kinase 2 alpha 1 Human Recombinant, His
Shipped with Ice Packs
In Stock

Description

Overview of CSNK2A1 Human, His

CSNK2A1 Human, His refers to a recombinant human casein kinase 2 alpha 1 (CK2α1) protein fused with a polyhistidine (His) tag. This protein is a catalytic subunit of the constitutively active serine/threonine-protein kinase CK2 complex, which regulates diverse cellular processes such as cell cycle progression, apoptosis, and circadian rhythm . The His tag facilitates purification and detection in experimental workflows .

Protein Architecture

  • Quaternary Structure: CK2α1 forms a tetrameric holoenzyme with two catalytic subunits (α/α') and two regulatory β-subunits .

  • Catalytic Domain: Residues 1–335 encompass the kinase domain, critical for ATP binding and substrate phosphorylation .

  • Post-Translational Modifications: Autophosphorylation occurs at Ser362, enhancing stability and activity .

Crystal Structures

PDB IDLigand/InhibitorResolution (Å)Key Findings
7A4C5,6,7-tribromo-1H-triazolo[4,5-b]pyridine1.55ATP-competitive inhibition; halogen bonding critical for inhibitor binding
7A496-bromo-5-chloro-1H-triazolo[4,5-b]pyridine1.60Structural basis for isoform selectivity in CK2α vs. CK2α'

Biological Processes

  • Cell Cycle Regulation: Phosphorylates CDC25B and CHEK1, modulating checkpoint control .

  • Neuromuscular Homeostasis: Conditional knockout in mice causes age-dependent muscle weakness, impaired autophagy, and fragmented neuromuscular junctions .

  • Ciliary Stability: Maintains primary cilia structure by opposing TTBK2 activity; mutations destabilize cilia tips and dysregulate Sonic Hedgehog signaling .

Key Substrates

SubstratePhosphorylation SiteFunctional Impact
PTENSer370/Ser385Modulates tumor suppression
RELASer536Enhances NF-κB transcriptional activity
APCMultiple sitesRegulates Wnt/β-catenin signaling

Okur-Chung Neurodevelopmental Syndrome (OCNDS)

  • Genetic Cause: De novo missense mutations (e.g., Arg47Gly, Lys198Arg) in CSNK2A1 .

  • Clinical Features: Intellectual disability, autistic traits, cortical malformations, and dysmorphic facial features .

  • Mechanism: Mutations disrupt kinase activity or substrate binding, leading to ciliary instability and aberrant signaling .

Cancer

  • Overexpression linked to breast adenocarcinoma (MCF-7) and leukemia (CCRF-CEM) cell proliferation .

Recombinant Protein Applications

  • Source: Produced in E. coli with ≥90% purity (Thermo Fisher, Cat# PV3992) .

  • Storage: Stable at -80°C for six months; avoid repeated freeze-thaw cycles .

Murine Knockout Phenotypes

ModelPhenotype
Csnk2a1 conditional KOReduced grip strength, mitochondrial dysfunction, increased autophagy
Csnk2a1 OCNDS variantsCiliary elongation, actin cytoskeleton defects

Inhibitors

CompoundIC₅₀ (CK2α)Mechanism
TBBt2.56 µMHalogenated triazolo-pyridine; competitive ATP binding
DMAT0.14 µMSelective CK2 inhibition; anti-proliferative effects

Mutation Hotspots in OCNDS

Mutation (Nucleotide)Protein ChangeClinical ImpactSource
c.593A>GLys198ArgImpaired kinase-substrate interaction
c.139C>GArg47GlyDisrupted ATP binding
c.468T>AAsp156GluAltered regulatory domain

Future Directions

Current research focuses on:

  • Developing isoform-specific CK2α inhibitors for cancer therapy .

  • Elucidating cilia-related mechanisms in OCNDS using patient-derived CSNK2A1 variants .

  • High-throughput screening to identify allosteric modulators of CK2α1 .

Product Specs

Introduction
Casein kinase 2 (EC2.7.11.1) is a serine/threonine-selective protein kinase that functions as a tetramer composed of two alpha subunits and two beta subunits. The alpha subunits contain the catalytic kinase domain. This kinase plays a role in various cellular processes, including cell cycle control, DNA repair, and the regulation of the circadian rhythm. Casein kinase 2 activity is known to be activated following the activation of the Wnt signaling pathway. A Pertussis toxin-sensitive G protein and Disheveled appear to mediate the connection between Wnt-mediated activation of the Frizzled receptor and the activation of casein kinase 2. Mice lacking casein kinase 2 alpha prime exhibit defects in the morphology of developing sperm.
Description
Recombinant human CSNK2A1, expressed in E. coli, is a single, non-glycosylated polypeptide chain containing 411 amino acids. It has a molecular weight of 47.3 kDa. This protein corresponds to the alpha subunit of Casein Kinase 2 and is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
CSNK2A1 is supplied in a buffer consisting of 20mM Tris pH 8.0, 500mM NaCl, 1mM DTT, and 50% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For long-term storage, freeze at -20°C. Avoid repeated freeze-thaw cycles.
Purity
Purity is greater than 90% as determined by SDS-PAGE analysis.
Synonyms
Casein kinase II subunit alpha, EC 2.7.11.1, CK II, CK2A1, CKII alpha, CSNK2A1, PKCK2, CSK21.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MSGPVPSRAR VYTDVNTHRP REYWDYESHV VEWGNQDDYQLVRKLGRGKY SEVFEAINIT NNEKVVVKIL KPVKKKKIKR EIKILENLRG GPNIITLADI VKDPVSRTPA LVFEHVNNTD FKQLYQTLTD YDIRFYMYEI LKALDYCHSM GIMHRDVKPH NVMIDHEHRK LRLIDWGLAE FYHPGQEYNV RVASRYFKGP ELLVDYQMYD YSLDMWSLGC MLASMIFRKE PFFHGHDNYD QLVRIAKVLG TEDLYDYIDK YNIELDPRFN DILGRHSRKRWERFVHSENQ HLVSPEALDF LDKLLRYDHQ SRLTAREAME HPYFYTVVKD QARMGSSSMP GGSTPVSSAN MMSGISSVPT PSPLGPLAGS PVIAAANPLG MPVPAAAGAQ Q.

Product Science Overview

Structure and Composition

The CK2 complex is a tetramer composed of two catalytic alpha subunits (CSNK2A1 and CSNK2A2) and two regulatory beta subunits (CSNK2B). The alpha subunits are responsible for the catalytic activity, while the beta subunits undergo autophosphorylation . The human recombinant form of CSNK2A1 is often tagged with a His-tag to facilitate purification and detection in research applications .

Function and Significance

CSNK2A1 is involved in numerous cellular processes, including:

  • Cell Cycle Control: It regulates the progression of the cell cycle by phosphorylating various substrates involved in cell division .
  • Apoptosis: CSNK2A1 plays a role in programmed cell death, influencing the balance between cell survival and apoptosis .
  • Circadian Rhythm: It is implicated in the regulation of circadian rhythms, affecting the body’s internal clock .
  • Transcription and Gene Expression: CSNK2A1 is involved in the regulation of transcription and gene expression by phosphorylating transcription factors and other proteins involved in these processes .
Clinical Relevance

Mutations in the CSNK2A1 gene have been associated with various disorders, including Okur-Chung Neurodevelopmental Syndrome and non-specific syndromic intellectual disability . These mutations can disrupt the normal function of the kinase, leading to developmental and neurological abnormalities.

Research Applications

The human recombinant form of CSNK2A1, tagged with a His-tag, is widely used in research to study its function and interactions. This recombinant protein is produced in various expression systems, such as baculovirus or E. coli, and is purified using chromatographic techniques . It is used in kinase assays, structural studies, and drug discovery efforts to develop inhibitors targeting CK2 activity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.